Cleared Special

K122240 - BONE PLUS BCP EAGLE EYE

K122240 is an FDA 510(k) clearance for BONE PLUS BCP EAGLE EYE, manufactured by Megagen Implant Co., Ltd.. The device is a Class 2 Dental device with product code LYC cleared through the Special 510(k) pathway after a 25-day FDA review.

K122240 · Megagen Implant Co., Ltd. · Dental device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Aug 2012
Decision
25d
Days
Class 2
Risk

K122240 is an FDA 510(k) clearance for the BONE PLUS BCP EAGLE EYE. Classified as Bone Grafting Material, Synthetic (product code LYC), Class II - Special Controls.

Submitted by Megagen Implant Co., Ltd. (Brea, US). The FDA issued a Cleared decision on August 21, 2012 after a review of 25 days - a notably fast clearance cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3930 - the FDA dental device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K122240

510(k) Number K122240 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 27, 2012
Decision Date August 21, 2012
Days to Decision 25 days
Submission Type Special
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
103d faster than avg
Panel avg: 128d · This submission: 25d
Pathway characteristics
Modification to existing cleared device.

LYC Device Classification - Class 2, Special Controls

Product Code LYC Bone Grafting Material, Synthetic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3930
Definition A Synthetic Bone Grafting Material Is Synthetically-derived Device, Such As Hydroxylapatite, Intended To Fill, Augment, Or Reconstruct Periodontal And Or Bony Defects Of The Upper Or Lower Jaw.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - LYC Bone Grafting Material, Synthetic

All 230
Devices cleared under the same product code (LYC) and FDA review panel - the closest regulatory comparables to K122240.
EASY-GRAFT
K131385 · Degradable Solutions AG · Sep 2013
CURASAN OSSEOLIVE DENTAL
K111105 · Curasan AG · Dec 2012
CERASORB DENTAL,CERADORB M DENTAL, CERASORB PERIO
K113282 · Riemser Arzeimittel AG · Sep 2012
SOCKET GRAFT
K113049 · Steiner Laboratories · Jan 2012
OSTEON II
K112716 · Genoss Co., Ltd. · Jan 2012
BLUE SKY BIO TCP
K110198 · Blue Sky Bio, LLC · Dec 2011
K122240 · BONE PLUS BCP EAGLE EYE
Download PDF FDA Summary Megagen Implant Co., …